OpenScience.ink

3 weeks ago • Frontiers in endocrinology

Latent autoimmune diabetes in two young women treated with oral semaglutide and long-acting insulinCase Report: Latent autoimmune diabetes in two young female patients successfully treated with oral semaglutide and basal insulin.

🎖️ Top 10% Journal

3 weeks ago • Diagnostics (Basel, Switzerland)

Can Fasting Levels of GLP-1 and GIP Predict How Well People Initially Respond to Semaglutide and Tirzepatide?Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide?

📖 Top 30% Journal

3 weeks ago • Journal of clinical medicine

Semaglutide as a useful treatment for irregular periods and lack of ovulation in women with polyendocrine metabolic ovarian syndromeEvidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome.

📖 Top 20% Journal

3 weeks ago • Diabetes/metabolism research and reviews

Link Between New Diabetes Drugs and Atrial Fibrillation Risk in Type 2 Diabetes Patients: Combined Analysis of StudiesNetwork and Pairwise Meta-Analysis of the Association Between Novel Hypoglycemic Agents and Atrial Fibrillation Risk in Patients With Type 2 Diabetes Mellitus.

🎖️ Top 10% Journal

3 weeks ago • Nutrients

A Plant-Based Treatment That Activates Two Key Metabolic Paths May Improve Obesity and Metabolism in Lab ModelsDual Activation of GLP-1 and AMPK Pathways by a Multi-Botanical Formulation Improves Obesity and Metabolic Dysfunction in Experimental Models.

🎖️ Top 10% Journal

3 weeks ago • Journal of clinical medicine

Insulin Glargine/Lixisenatide's 12-Month Effects on Weight, Natural Insulin Production, and Kidney Health Beyond Blood Sugar ControlBeyond Glycemic Control: Real-World 12-Month Effects of Insulin Glargine/Lixisenatide on Weight, Endogenous Insulin Secretion, and Albuminuria.

📖 Top 20% Journal

3 weeks ago • The lancet. Gastroenterology & hepatology

Safety and effectiveness of zalfermin with semaglutide in people with liver scarring from metabolic-related fatty liver disease: a phase 2 dose studyEfficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial.

🥇 Top 1% Journal

3 weeks ago • Cardiovascular toxicology

Incretin-Based Treatments and Their Role in Heart Damage Caused by Doxorubicin: A Review of GLP-1 and Combined GIP/GLP-1 TherapiesIncretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists.

📖 Top 30% Journal

3 weeks ago • BMJ open gastroenterology

How GLP-1-based treatment relates to small bowel movement speed during capsule endoscopyAssociation between GLP-1-based therapy and small-bowel transit time during capsule endoscopy: a prospective, multicentre, observational study.

📖 Top 20% Journal

3 weeks ago • Journal of clinical medicine

Changes in Blood Sugar-Regulating Hormones During Endurance Training in Competitive TriathletesChanges in GLP-1 and GIP During Endurance Training in Competitive Triathletes: A Pilot Observational Study.

📖 Top 20% Journal

3 weeks ago • Diagnostics (Basel, Switzerland)

Tracking Bone Loss During GLP-1RA Treatment Using a Urine Test for Bone BreakdownTracking Bone Loss in GLP-1RA Therapy: The Potential of the Deoxypyridinoline Urine Test.

📖 Top 30% Journal

3 weeks ago • The lancet. Psychiatry

Links between GLP-1 receptor drugs and hospital stays for alcohol and drug problems during and after treatmentAssociation of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study.

🥇 Top 1% Journal

3 weeks ago • Diabetes & metabolism journal

Semaglutide and Exercise Together Help Keep Muscle and Reveal Organ Communication in ObesitySemaglutide and Exercise Synergy in Obesity: Preserving Muscle Mass and Uncovering Organ Crosstalk.

3 weeks ago • Endocrine journal

Tirzepatide use in older adults with type 2 diabetes and its links to low blood sugar risk and weight lossReal-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

📖 Top 30% Journal

3 weeks ago • Laryngoscope investigative otolaryngology

Heart Protection by GLP-1 Agonists in People with Sleep Apnea and Their Heart RiskCardio-Protective Effect of GLP-1 Agonists in OSA Patients: A Study of Cardiovascular Risk.

📖 Top 30% Journal

3 weeks ago • BMC gastroenterology

Effects of Glucagon-like Peptide-1 Drugs on Pancreas Health in Chronic Pancreatitis PatientsGlucagon-like peptide-1 receptor agonists and pancreatic outcomes in chronic pancreatitis: a real-world cohort study.

📖 Top 30% Journal

3 weeks ago • High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Comparing heart disease risk estimates for Orforglipron using two prediction modelsExploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis.

📖 Top 20% Journal

3 weeks ago • Diabetes technology & therapeutics

New Cases of Diabetic Eye Disease After One Year of Adding Tirzepatide in Adults with Type 1 DiabetesIncident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes.

🥈 Top 2% Journal

3 weeks ago • Innere Medizin (Heidelberg, Germany)

Recent Advances in Hormone and Diabetes Research[New developments in endocrinology/diabetology].

3 weeks ago • Pharmaceutical development and technology

Temperature-Responsive Gels for Slow Semaglutide Release to Break Weight Loss Plateaus in Obese RatsThermosensitive hydrogels for sustained semaglutide release: overcoming weight loss plateau in diet-induced obese rats.

📖 Top 50% Journal

3 weeks ago • The Journal of endocrinology

Exendin-4 may improve high sugar damage to energy centers in insulin-producing cells through PKA/Drp1 signalsExendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling.

3 weeks ago • Journal of laparoendoscopic & advanced surgical techniques. Part A

Weight loss and health results of metabolic surgery compared to GLP-1 drug treatment in 14,548 patientsComparative Outcomes of Metabolic and Bariatric Surgery Versus GLP-1 Receptor Agonists: An Updated Systematic Review and Meta-Analysis of 14,548 Patients.

📖 Top 50% Journal

3 weeks ago • Diabetes, obesity & metabolism

Effects of GLP-1 and Combined GIP/GLP-1 Drugs on Inflammation and Metabolism in Type 2 DiabetesEffects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

3 weeks ago • Diabetes, obesity & metabolism

Amylin-like Drugs as a New Major Option for Weight Loss: Review of Lab and Early Human StudiesAmylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.

3 weeks ago • International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Glucagon-like peptide-1 receptor agonist and opioid use after gynecologic surgeryGlucagon-like peptide-1 receptor agonist and post-operative opioid consumption in gynecologic surgery.

🎖️ Top 10% Journal

3 weeks ago • Endocrine connections

Use of GLP-1 Receptor Drugs Around Conception and Risk of Major Birth Defects: A Review and AnalysisPericonceptional use of GLP-1 receptor agonists and the risk of major congenital malformations: a systematic review and meta-analysis.

📖 Top 20% Journal

3 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

How GLP-1 Drugs, Exercise, and Both Together Affect Body Fat and Sugar-Fat Metabolism in Overweight AdultsComparative Efficacy of GLP-1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta-Analysis of Randomized Controlled Trials.

3 weeks ago • The Journal of clinical endocrinology and metabolism

Differences between people in stomach emptying relate to GLP-1 hormone response after sugar enters the small intestine in healthy individualsInter-individual variation in gastric emptying is related to GLP-1 response to intraduodenal glucose exposure in health.

🥉 Top 5% Journal

3 weeks ago • Obesity surgery

Best time to start Liraglutide 3.0 mg for patients with ongoing obesity six months after weight-loss surgeryOptimal Timing for Initiating Liraglutide 3.0 mg in Patients With Persistent Obesity Six Months After Metabolic and Bariatric Surgery.

📖 Top 20% Journal

3 weeks ago • ACS medicinal chemistry letters

Finding molecules that selectively activate both blood sugar and energy control receptors by changing a key protein partDiscovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate.

📖 Top 30% Journal

← prevpage 10 of 15next →

Latest GLP-1 Therapies Research Papers